BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 20100034)

  • 1. Aerodynamic characteristics of nebulized terbutaline sulphate using the Andersen Cascade Impactor compared to the Next Generation Impactor.
    Abdelrahim ME
    Pharm Dev Technol; 2011 Apr; 16(2):137-45. PubMed ID: 20100034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aerodynamic characteristics of nebulized terbutaline sulphate using the Next Generation Impactor (NGI) and CEN method.
    Abdelrahim ME; Chrystyn H
    J Aerosol Med Pulm Drug Deliv; 2009 Mar; 22(1):19-28. PubMed ID: 19392586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of methods to measure aerosols generated by a vibrating mesh nebulizer.
    Waldrep JC; Berlinski A; Dhand R
    J Aerosol Med; 2007; 20(3):310-9. PubMed ID: 17894537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aerodynamic particle size analysis of aerosols from pressurized metered-dose inhalers: comparison of Andersen 8-stage cascade impactor, next generation pharmaceutical impactor, and model 3321 Aerodynamic Particle Sizer aerosol spectrometer.
    Mitchell JP; Nagel MW; Wiersema KJ; Doyle CC
    AAPS PharmSciTech; 2003 Oct; 4(4):E54. PubMed ID: 15198549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical nebulizer performance: effects of cascade impactor temperature.
    Zhou Y; Ahuja A; Irvin CM; Kracko DA; McDonald JD; Cheng YS
    Respir Care; 2005 Aug; 50(8):1077-82. PubMed ID: 16225713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of impactor operating flow rate on particle size distribution of four jet nebulizers.
    Zhou Y; Brasel TL; Kracko D; Cheng YS; Ahuja A; Norenberg JP; Kelly HW
    Pharm Dev Technol; 2007; 12(4):353-9. PubMed ID: 17763140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of a procedure used to measure aerosol characteristics of nebulized solutions using a cooled next generation impactor.
    Berlinski A; Hayden JB
    J Aerosol Med Pulm Drug Deliv; 2010 Dec; 23(6):397-404. PubMed ID: 20958142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of nebulized particle size distribution with Malvern laser diffraction analyzer versus Andersen cascade impactor and low-flow Marple personal cascade impactor.
    Kwong WT; Ho SL; Coates AL
    J Aerosol Med; 2000; 13(4):303-14. PubMed ID: 11262437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of a droplet evaporation model to aerodynamic size measurement of drug aerosols generated by a vibrating mesh nebulizer.
    Rao N; Kadrichu N; Ament B
    J Aerosol Med Pulm Drug Deliv; 2010 Oct; 23(5):295-302. PubMed ID: 20455771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of nebulizer droplet size distribution: a method based on impactor refrigeration.
    Berg E; Svensson JO; Asking L
    J Aerosol Med; 2007; 20(2):97-104. PubMed ID: 17536948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring charge and mass distributions in dry powder inhalers using the electrical Next Generation Impactor (eNGI).
    Hoe S; Traini D; Chan HK; Young PM
    Eur J Pharm Sci; 2009 Sep; 38(2):88-94. PubMed ID: 19559086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of delivery characteristics from a combination metered-dose inhaler using the Andersen cascade impactor and the next generation pharmaceutical impactor.
    Guo C; Gillespie SR; Kauffman J; Doub WH
    J Pharm Sci; 2008 Aug; 97(8):3321-34. PubMed ID: 17932959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aerodynamic sizing of metered dose inhalers: an evaluation of the Andersen and Next Generation pharmaceutical impactors and their USP methods.
    Kamiya A; Sakagami M; Hindle M; Byron PR
    J Pharm Sci; 2004 Jul; 93(7):1828-37. PubMed ID: 15176070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aerodynamic deposition of combination dry powder inhaler formulations in vitro: a comparison of three impactors.
    Taki M; Marriott C; Zeng XM; Martin GP
    Int J Pharm; 2010 Mar; 388(1-2):40-51. PubMed ID: 20026261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro comparison of the circulaire and AeroTee to a traditional nebulizer T-piece with corrugated tubing.
    Piper SD
    Respir Care; 2000 Mar; 45(3):313-9. PubMed ID: 10771800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Aerodynamic Particle Size Distribution Between a Next Generation Impactor and a Cascade Impactor at a Range of Flow Rates.
    Yoshida H; Kuwana A; Shibata H; Izutsu KI; Goda Y
    AAPS PharmSciTech; 2017 Apr; 18(3):646-653. PubMed ID: 27173989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Output and aerosol properties of 5 nebulizer/compressor systems with arformoterol inhalation solution.
    Bauer A; McGlynn P; Bovet LL; Mims PL; Curry LA; Hanrahan JP
    Respir Care; 2009 Oct; 54(10):1342-7. PubMed ID: 19796414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cooling the NGI - an approach to size a nebulised aerosol more accurately.
    Dennis J; Berg E; Sandell D; Ali A; Lamb P; Tservistas M; Karlsson M; Mitchell J
    Pharmeur Sci Notes; 2008 Feb; 2008(1):27-30. PubMed ID: 18430404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of physical and inhalation properties of spray-dried and micronized terbutaline sulphate.
    Thi TH; Danède F; Descamps M; Flament MP
    Eur J Pharm Biopharm; 2008 Sep; 70(1):380-8. PubMed ID: 18504120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of tubing deposition, breathing pattern, and temperature on aerosol mass distribution measured by cascade impactor.
    Gurses BK; Smaldone GC
    J Aerosol Med; 2003; 16(4):387-94. PubMed ID: 14977429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.